PTHrP-mediated hypercalcemia comprises approximately 80% of cases of hypercalcemia of malignancy, most commonly in squamous cell carcinomas and rarely in sarcomas [1, 2]. The gene discussed is PTHLH; the disease is hypercalcemia disease.